A healthy heart is a pliable, ever-moving organ. But under stress—from injury, cardiovascular disease, or aging—the heart thickens and stiffens in a process known as fibrosis, which involves diffuse scar-like tissue. ...
Jun 23, 2021
0
13
Researchers at the University of Maryland School of Medicine (UMSOM) analyzed data at the 13-hospital University of Maryland Medical System (UMMS) and found public health measures designed to reduce the spread of the COVID-19 ...
Jun 14, 2021
0
4
The concept of rationing medical resources during the height of COVID-19 pandemic created tremendous anxiety in the patient and healthcare communities. In planning for that possibility, Massachusetts created a triage scoring ...
Jun 14, 2021
0
0
According to the Global Burden of Disease Study 2017, close to nine percent of the global population lives with some form of chronic kidney disease, or CKD. Not only does the condition affect renal function, but CKD has long ...
Jun 4, 2021
0
13
How we now treat COVID-19 pneumonia compared to 12 months ago makes a significant difference to survival.
May 19, 2021
0
11
Patients with chronic kidney disease and Type 2 diabetes who took the experimental drug finerenone were about 30% less likely to develop the heart rhythm disorder atrial fibrillation (AFib) than those taking a placebo, according ...
May 17, 2021
0
2
Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, did not significantly reduce the risk of organ failure or death or improve recovery in patients hospitalized with COVID-19 who are at high risk of developing ...
May 17, 2021
0
3
Heart failure (HF) - when the heart can't pump enough blood and oxygen through the body—affects approximately 6.2 million adults in the United States and is the primary cause of hospitalization in the elderly. Unfortunately, ...
May 16, 2021
0
2
The global spread of COVID-19 has raised serious concern for patients with chronic disease. A correlation has been identified between the severity of COVID-19 and a patient's preexisting comorbidities. Although COVID-19 primarily ...
May 6, 2021
0
2
(HealthDay)—Farxiga (dapagliflozin) oral tablets are now approved for adults with chronic kidney disease at risk for disease progression, the U.S. Food and Drug Administration announced Friday.
May 4, 2021
0
9
